Aurobindo Pharma Ltd.
| BSE: 524804 | Sector: Health care |
| NSE: AUROPHARMA | ISIN Code: INE406A01037 |
| BSE 00:00 | 24 Apr | Aurobindo Pharma Ltd |
| NSE 05:30 | 01 Jan | Aurobindo Pharma Ltd |
| OPEN | 630.00 |
| PREVIOUS CLOSE | 628.95 |
| VOLUME | 446467 |
| 52-Week high | 838.00 |
| 52-Week low | 281.15 |
| P/E | 22.74 |
| Mkt Cap.(Rs cr) | 36,557 |
| Buy Price | 626.00 |
| Buy Qty | 45.00 |
| Sell Price | 627.25 |
| Sell Qty | 50.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Aurobindo Pharma Ltd. (AUROPHARMA) - Financial Ratios
| Ratios | 2019 | 2018 | 2017 |
| Debt-Equity Ratio | 0.39 | 0.37 | 0.47 |
| Current Ratio | 1.51 | 1.52 | 1.47 |
| Asset turnover ratio | 2.52 | 2.56 | 2.97 |
| Inventory turnover ratio | 3.32 | 3.53 | 4.02 |
| Debtors turnover ratio | 2.53 | 2.50 | 2.40 |
| Interest Coverage ratio | 9.51 | 45.30 | 49.24 |
| Operating Margin (%) | 21.28 | 26.70 | 25.66 |
| Net Profit Margin (%) | 12.48 | 17.59 | 17.45 |
| Return on Capital Employed (%) | 14.82 | 18.98 | 19.71 |
| Return on Net Worth (%) | 14.34 | 19.68 | 22.31 |
Quick Links for Aurobindo Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
